First Trust Direct Indexing’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-60,910	Closed	-$968K	–	706
2024 Q3	$968K	Buy	60,910 +3,890	+7%	+$62.6K	0.05%	354
2024 Q2	$869K	Buy	57,020 +3,850	+7%	+$55.2K	0.05%	345
2024 Q1	$780K	Buy	53,170 +1,255	+2%	+$18.3K	0.06%	350
2023 Q4	$722K	Buy	51,915 +6,130	+13%	+$82K	0.06%	342
2023 Q3	$612K	Buy	45,785 +4,570	+11%	+$61.8K	0.07%	336
2023 Q2	$520K	Sell	41,215 -685	-2%	-$8K	0.06%	402
2023 Q1	$477K	Buy	41,900 +5,845	+16%	+$63.1K	0.06%	412
2022 Q4	$373K	Buy	36,055 +6,010	+20%	+$64.8K	0.05%	452
2022 Q3	$315K	Buy	30,045 +2,855	+11%	+$30.4K	0.05%	453
2022 Q2	$301K	Buy	27,190 +3,110	+13%	+$33.8K	0.04%	469
2022 Q1	$268K	Buy	24,080 +1,720	+8%	+$19.5K	0.03%	537
2021 Q4	$293K	Sell	22,360 -500	-2%	-$6.3K	0.04%	498
2021 Q3	$298K	Sell	22,860 -4,285	-16%	-$57.1K	0.04%	474
2021 Q2	$399K	Buy	+27,145	New	+$380K	0.06%	384